Inspire Medical Systems (INSP) Cash from Financing Activities (2017 - 2026)

Inspire Medical Systems has disclosed Cash from Financing Activities across 10 years of filings, most recently posting $1.9 million for Q2 2026.

• In Q2 2026, Cash from Financing Activities fell 48.31% year-over-year to $1.9 million; the TTM figure through Jun 2026 stood at -$105.0 million (up 27.27% YoY), while the FY2025 annual figure was -$183.4 million, down 250.14% from the prior year.
• Cash from Financing Activities came in at $1.9 million for Q2 2026 at Inspire Medical Systems, up from -$7.5 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $224.1 million in Q3 2022 to a low of -$87.8 million in Q1 2025.
• Average Cash from Financing Activities over 5 years is $423000.0, with a median of $2.5 million recorded in 2022.
• Year-over-year, Cash from Financing Activities jumped 5732.03% in 2022 and slumped 11527.08% in 2025.
• Over 5 years, Cash from Financing Activities stood at $7.3 million in 2022, then tumbled by 238.77% to -$10.1 million in 2023, then tumbled by 593.41% to -$70.1 million in 2024, then soared by 31.12% to -$48.3 million in 2025, then soared by 103.96% to $1.9 million in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were $1.9 million in Q2 2026, -$7.5 million in Q1 2026, and -$48.3 million in Q4 2025.